Ero posts formal report for its Brazil copper-gold project study

Ero Copper (ERO) reported Q2 2026 revenue of $284.3 million, up 8% sequentially, and adjusted EBITDA of $144 million, up from $125.2 million, helped by higher copper prices and gold volumes. Cash flow from operations was $137.9 million. Net debt fell to $452.7 million. Guidance: copper 67,500-77,500 tonnes; mined gold 40,000-50,000 oz.

Ero Copper (NYSE: ERO) reported Q2 call highlights. At Tucumã, copper output rose 6% sequentially to 8,964 tonnes, with throughput up 27% to ~250,000 to 260,000 tonnes/month. At Xavantina, gold production rose 170% to over 20,000 oz. Q2 revenue was $284.3m; net debt fell $38m to ~$453m. 2026 mined-gold C1 guidance is $1,100-$1,350/oz and AISC $2,200-$2,700/oz.

TD Cowen analyst Mario Mendonca raised targets for Canadian insurers, citing strong equity markets and expected Q2/26 earnings growth. Great-West Lifeco (GWO) target to $98, Manulife (MFC) to $65, Sun Life (SLF) to $121, IA Financial (IAG) to $214. Stifel lifted copper price forecasts to $6.04/lb in 2026 and raised targets for CS, ERO, FM, FCX, HBM. National Bank Financial upgraded Tidewater Midstream (TWM) to Outperform.

Microsoft (MSFT) received a BUY rating and $600 price target from 24/7 Wall St., citing 43% Azure growth and a $678B commercial RPO backlog. The stock is up 27.81% over the past month and 3.29% year-to-date, with Q4 FY26 revenue of $90.01B and non-GAAP EPS of $4.74. The target implies 18.9% upside, potentially pushing market cap to $5T. Bulls highlight demand outpacing supply, while bears note capital intensity and declining PC revenue.

Eli Lilly and Company's Kenosha facility, acquired in 2024, is part of a $4 billion investment in Wisconsin for injectable medicine production. The site, which received FDA approval in 18 months, is producing drugs like Zepbound and Mounjaro. The facility is expected to support 750 jobs and has attracted attention due to its strategic location and skilled workforce. Wisconsin has also joined a lawsuit against the Trump administration's family planning funding rules. The state collected $450.8 mi

Exelon's CFO Jeanne Jones transitions to a new role as EVP of finance and strategy on Oct. 5, focusing on long-term strategy and capital allocation. Robert Kleczynski will succeed Jones as CFO. Exelon reported Q2 revenue of $5.97 billion, up 10% YoY, beating estimates. The company is investing in infrastructure amid rising electricity demand and pressure to keep customer bills affordable.